Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Elizabeth Keating

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pathology|November 18, 2022
Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case studyKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Rheumatology (Oxford, England)|May 25, 2024
Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared with European populations in Aotearoa/New ZealandKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Pathology|July 3, 2021
HMGCR autoantibody testing: two tiers requiredKe Li Chow, Paula Elizabeth Keating, Myfanwy Bailey Spellerberg, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New ZealandKe Li Chow, Paula Elizabeth Keating, Kamal Solanki, et al.
Therapeutic Drug Monitoring|April 22, 2024
Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical LaboratoryPaula Elizabeth Keating, Barry D Hock, Paul K L Chin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pathology|November 18, 2022
Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case studyKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Rheumatology (Oxford, England)|May 25, 2024
Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared with European populations in Aotearoa/New ZealandKe Li Chow, Paula Elizabeth Keating, John Liston O'Donnell
Pathology|July 3, 2021
HMGCR autoantibody testing: two tiers requiredKe Li Chow, Paula Elizabeth Keating, Myfanwy Bailey Spellerberg, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New ZealandKe Li Chow, Paula Elizabeth Keating, Kamal Solanki, et al.
Therapeutic Drug Monitoring|April 22, 2024
Evaluation of the Homogenous Mobility Shift Assay for Infliximab and Adalimumab Anti-drug Antibody Detection in the Clinical LaboratoryPaula Elizabeth Keating, Barry D Hock, Paul K L Chin, et al.
Pageof 1